Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home About Us
In the News

April 14, 2014
Bioniche Life Sciences Inc. Shareholders Approve Sale of Animal Health Business

April 3, 2014
ISS Recommends that Bioniche Shareholders Vote in Favour of Animal Health Sale Transaction


Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Management Team

Dr. Michael Berendt
Chief Executive Officer

Cindy Benning
Senior Vice-President, Operations, Quality & Regulatory Affairs

Debi Butler
Vice-President and Corporate Controller

Monique Champagne
Vice-President, Clinical Research

Rick Culbert
President, One Health

Mohamed Elrafih
Vice-President, Manufacturing Operations

Brian Ford
Chief Financial Officer

Andrew Grant
President, Bioniche Animal Health (global)

Donald Olds
Chief Operating Officer

Mairi Phillips
Vice-­President, Legal Services & Corporate Secretary

Jennifer Shea
Vice-President, Communications, Investor & Government Relations

Senior Management Biographies

Dr. Michael BerendtDR. MICHAEL BERENDT
CEO, Bioniche Life Sciences Inc.

Dr. Michael Berendt was appointed as CEO of the Company on November 4, 2013.

  • In 2006, he became the President & CEO of Aegera, which was sold to Pharmascience in 2011
  • Worked in the U.S. research departments of Pfizer, Inc. and Bayer Corporation before becoming Managing Director, Life Sciences Sector of AEA Investors, then Managing Director of Research Corporation Technologies
  • Dr. Berendt graduated with a B.S. from Ohio Dominican University, a M.S. from Miami University, and a Ph.D. in Medical Microbiology and Immunology from Drexel University.
  • Dr. Berendt is a Director on the Boards of Waters Corporation and NeoMed Institute.
  • He serves as Executive Chairman of Anchor Therapeutics and serves as Chairman of Alethia Biothérapeutiques.


Senior Vice-President, Operations, Quality & Regulatory Affairs

  • Holds a Technology Diploma in Biological Sciences from St. Clair College, a Bachelor of Science Degree from the University of Waterloo, and an MBA from Athabasca University.
  • Joined Bioniche in 1993 as Quality Control Supervisor.
  • Was appointed as Vice-President, Corporate Quality & Regulatory Affairs in December, 2001 with added responsibility for Operations in June 2005; was promoted to Senior Vice-President in September, 2011.
  • Has more than 21 years of experience in the pharmaceutical industry, holding various positions in Quality Control and/or Regulatory Affairs.
  • Has extensive experience in GMP, cGMP, and Quality Assurance, as well as in Regulatory Affairs for both human and veterinary health products in international regulatory markets.


Vice-President and Corporate Controller

  • Is a Certified General Accountant
  • Received her Honours Bachelor of Commerce degree from Laurentian University
  • Joined Bioniche in 2000, holding increasingly responsible roles in the Finance Department before being appointed as Corporate Controller in 2009. She was promoted to Vice-President and Corporate Controller in 2012.
  • Has more than 30 years of accounting experience gained in the fields of banking, public accounting, and both private and publicly traded companies.


Vice-President, Clinical Research

  • Joined Bioniche in March, 2006 as Director, Clinical Research with 19 years of experience in international research
  • Held research and development management positions at Xanthus Life Sciences, Supratek Pharma Inc., PriceWaterhouseCoopers, Quintiles Canada, Wyeth-Ayerst Research and Scat Canada Inc.
  • Received a Masters degree in Pharmaceutical Science and a Bachelors degree in Pharmacy both from the University of Montréal.


President, One Health

  • Has a diploma from Animal Health Technology from Centralia College of Agricultural Technology; is a graduate of the Advanced Agricultural Leadership Program, University of Guelph.
  • Joined Bioniche (then Vetrepharm Inc.) in 1980 as Ontario Regional Manager.
  • Held progressively senior roles in the Animal Health division of the Company before being appointed as President of Bioniche Animal Health Canada, Inc. in 2002; was promoted to President, Bioniche Food Safety in July, 2007 and assumed the role of President, Bioniche One Health in February, 2013.
  • Served on the Canadian Animal Health Institute Board of Directors for 9 years, including 2 years as Chairman.


Vice-President, Manufacturing Operations

  • Graduated from the University of Western Ontario with a Bachelor's Degree in Science (Microbiology).
  • Has more than 19 years' experience in the pharmaceutical industry.
  • Joined Bioniche in 1984 and became Vice-President, Manufacturing Operations in November, 2001.
  • Responsible for all manufacturing and plant operations for BLSI.


Chief Financial Officer

  • Has a Graduate Diploma in Accounting from the University of McGill and a B.A. (Economics, History, English) from the University of Guelph; is a member of the Ontario Institute of Chartered Accountants.
  • Has more than 26 years of experience serving private corporations and publicly traded entities.
  • Held increasingly responsible positions with Ernst & Young, with his last position being Principal of Business Risk Services in the firm's Toronto office
  • Prior to joining Bioniche Life Sciences Inc. in September, 2009, was Proprietor of PetersFord Consulting, a firm focused on finance and business risk services.


President, Bioniche Animal Health (global)

  • Joined the Company as Managing Director of Bioniche Animal Health Asia in 1998 after having worked for 12 years with Boehringer Ingelheim as Sales and Product Manager.
  • Served as Managing Director, Bioniche Animal Health Europe from 2005 to 2007.
  • Served as Divisional President, Bioniche Animal Health Export Sales, Europe and A/Asia in July, 2007.
  • Promoted to current role in January, 2011.
  • Graduated from the University of Technology, Sydney with a Diploma in Advanced Marketing.


Chief Operating Officer

  • Holds a B.Sc. from the University of British Columbia, as well as a M.Sc. and a MBA from McGill University.
  • Appointed in January, 2014.
  • Was President & CEO of Presagia Corp. (Montreal, Quebec) prior to joining Bioniche. Previously served as Chief Operating Officer and Chief Financial Officer at Aegera Therapeutics (Montreal, Quebec) and Vice-President and Director at TD Securities, among other executive positions.
  • Has executive level experience in biotechnology, investment banking, and information technology, where he has led successful licensing, merger and acquisition, and debt and equity transactions for both public and private companies.
  • Is Chairman of the Board of the Neomed Institute, Director and Chair of the Audit Committee of the Consortium Québécois sur la Découverte du Médicament, Director of Bellus Health, and Treasurer of Oxfam Quebec.


Vice­-President, Legal Services & Corporate Secretary

  • Joined Bioniche in 2002 as Legal Assistant
  • Subsequently promoted to In­House Law Clerk, then Manager, Legal Services, then Director, Legal Services, then Vice­President, Legal Services
  • Graduated from Canadore College in 1989; is a Notary Public
  • Worked as a Law Clerk/Paralegal for 22 years in Colorado, Ontario and British Columbia.


Vice-President, Communications, Investor & Government Relations

  • Joined Bioniche in April, 2004
  • Previously worked in progressive Corporate Communications positions with hospitals in Kingston and Belleville, Ontario for 18 years.
  • Graduated from Loyalist College with a diploma in Broadcast Journalism.


Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy